Search

Search Results

• 

  Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis

  B. Ruaro, S. Paolino, C. Pizzorni, M. Cutolo, A. Sulli

  134-136

  21-09-2017

  Published: 21 September 2017

  2120

  PDF: 945
• 

  Successful treatment of refractory adult onset Still’s disease with rituximab

  N. Belfeki, M. Smiti Khanfir, F. Said, A. Hamzaoui, T. Ben Salem, I. Ben Ghorbel, M. Lamloum, M.H. Houman

  159-162

  16-12-2016

  Published: 16 December 2016

  1971

  PDF: 1137
• 

  Acute colchicine overdose: report of three cases

  A. Aghabiklooei, N. Zamani, H. Hassanian-Moghaddam, S. Nasouhi, M. Mashayekhian

  307-311

  17-03-2014

  Published: 17 March 2014

  3666

  PDF: 1478
• 

  Cognitive-behavioral and operant-behavioral therapy for people with fibromyalgia

  K. Thieme, D.C. Turk

  275-285

  28-09-2012

  Published: 28 September 2012

  2913

  PDF: 2871
• 

  Glucocorticoid-induced osteoporosis: 2013 update

  M. Mazzantini, O. Di Munno

  144-152

  28-07-2014

  Published: 28 July 2014

  3417

  PDF: 2130
• 

  Sarcoidosis presenting as orbital pseudotumor

  S. Kobak, A. Topaloglu, G. Öncel, A. Karaarslan

  78-81

  16-09-2015

  Published: 16 September 2015

  1808

  PDF: 989

• Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project

  L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio

  54-64

  Published:

  1187

  PDF: 1007

• Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

  I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

  267-272

  Published:

  995

  PDF: 1547

• Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases

  H. Marotta, R. Montisci, F. Tiso, S. Pontarollo, M. Rizzo, F. Tona, S. Iliceto, F. Cozzi

  299-303

  Published:

  869

  PDF: 688
• 

  Predictors of thickened carotid intima media thickness among well controlled lupus nephritis patients in a Malaysian tertiary centre

  S.S. Shaharir, M.S. Mohamed Said, N.CT. Kong

  341-349

  20-12-2012

  Published: 20 December 2012

  2038

  PDF: 842

• How much does an antiinflammatory treatment cost?

  D. Gatti, O. Viapiana, G. Colombo, S. Adami

  248-252

  Published:

  1191

  PDF: 634

• Italian guidelines for the diagnosis and treatment of Paget’s disease of bone

  S. Adami, P. Bartolazzi, M.L. Brandi, A. Falchetti, P. Filipponi, S. Gonnelli, G. Bianchi, G.C. Isaia, R. Nuti

  153-168

  Published:

  1568

  PDF: 5896
• 

  Italian Society of Rheumatology recommendations for the management of gout

  M. Manara, A. Bortoluzzi, M. Favero, I. Prevete, C.A. Scirè, G. Bianchi, C. Borghi, M. A. Cimmino, G. M. D'Avola, G. Desideri, G. Di Giacinto, M. Govoni, W. Grassi, A. Lombardi, M. Marangella, M. Matucci Cerinic, G. Medea, R. Ramonda, A. Spadaro, L. Punzi, G. Minisola

  4-21

  28-03-2013

  Published: 28 March 2013

  5491

  PDF: 1475
• 

  Somatoform disorders and rheumatic diseases: from DSM-IV to DSM-V

  A. Alciati, F. Atzeni, P. Sgiarovello, P. Sarzi-Puttini

  98-102

  06-06-2014

  Published: 6 June 2014

  1711

  PDF: 1151

• Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis

  U. Fiocco, P. Sfriso, F. Oliviero, F. Sovran, E. Scagliori, E. Pagnin, M. Vezzù, L. Cozzi, C. Botsios, R. Nardacchione, A. Di Maggio, L. Rubaltelli, C. Giacometti, F. Calabrese, S. Todesco

  268-274

  Published:

  1478

  PDF: 2627

• Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology

  M. Manara, D. Bruno, M. Ferrito, S. Perniola, R.F. Caporali, E. Gremese

  11-09-2024

  Published: 11 September 2024

  910

  PDF: 467

• On the main stages of the history of intra-articular therapy

  P. Marson, G. Pasero, L. Punzi, G. Zanchin

  262-268

  Published:

  1287

  PDF: 1087
• 

  Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis

  G. Andrisani, E. Gremese, L. Guidi, A. Papa, M. Marzo, C. Felice, D. Pugliese, A. Armuzzi

  75-78

  27-05-2013

  Published: 27 May 2013

  2858

  PDF: 851

• Rééducation Posturale Globale in musculoskeletal diseases: scientific evidence and clinical practice

  C. Vanti, A. Generali, S. Ferrari, T. Nava, D. Tosarelli, P. Pillastrini

  192-201

  Published:

  3585

  PDF: 3507
• 

  RETRACTED - Pain in systemic sclerosis

  S. Stisi, P. Sarzi-Puttini, M. Benucci, G. Biasi, S. Bellissimo, R. Talotta, F. Atzeni

  44-47

  06-06-2014

  Published: 6 June 2014

  1948

  PDF: 1083

• The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis

  M. Varenna, D. Gatti

  163-171

  Published:

  1686

  PDF: 1120
• 

  Treatment of hyperuricemia, gout and other crystalline arthritidies

  F. Lioté

  276-283

  Published:

  1067

  PDF: 996

• Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

  A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

  233-238

  Published:

  981

  PDF: 955

• Incidence and management of infusion reactions to infliximab in 186 italian patient’s with rheumatoid arthritis: the Padua experience

  C. Botsios, P. Ostuni, S. Todesco

  44-51

  Published:

  1111

  PDF: 1708
• 

  Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?

  J. Mencarini, M. Spinicci, F. Bartalesi

  144-147

  16-12-2016

  Published: 16 December 2016

  1529

  PDF: 1049
• 

  Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers

  E. Catarsi, M. Doveri, A. Tavoni

  79-81

  27-05-2013

  Published: 27 May 2013

  2987

  PDF: 812
• 

  CTLA4-Ig interferes and downregulates the proinflammatory activities of rheumatoid synovial macrophages in monoculture

  R. Brizzolara, S. Soldano, P. Montagna, A. Sulli, B. Seriolo, B. Villaggio, P.F. Triolo, P. Clerico, L. Felli, L. Molfetta, M. Cutolo

  80-85

  Published:

  1284

  PDF: 926
• 

  Mesenchimal stem cells: a possible role in the pathogenesis and treatment of spondyloarthritis

  F.M. Perrotta, G. Guerra, A. De Socio, S. Scriffignano, E. Lubrano

  1-8

  22-05-2017

  Published: 22 May 2017

  2233

  PDF: 1397
• 

  Chronic widespread pain in spondyloarthritis

  F. Atzeni, L. Boccassini, M. Di Franco, A. Alciati, A. Marsico, M. Cazzola, G. Cassisi, P. Sarzi-Puttini

  28-32

  06-06-2014

  Published: 6 June 2014

  2291

  PDF: 1536
• 

  The diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: the good, the bad and… ultrasonography!

  G. Filippou, B. Frediani

  125-127

  19-07-2012

  Published: 19 July 2012

  787

  PDF: 771
• 

  Osteoporosis and rheumatic diseases

  N. Maruotti, A. Corrado, F.P. Cantatore

  125-135

  28-06-2014

  Published: 28 June 2014

  7438

  PDF: 3190

• Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFα treatment

  M. Di Gangi, R. Foti, R. Leonardi, C. Leonetti, P. Castellino

  169-172

  Published:

  917

  PDF: 844
• 

  Biomarkers and prognostic stratification in psoriatic arthritis

  L. Bogliolo, G. Crepaldi, R. Caporali

  88-98

  05-06-2012

  Published: 5 June 2012

  1295

  PDF: 1266

• Efficacy of Carbopol 974P (Siccafluid) in the treatment of severe to moderate keratoconjunctivitis sicca (KCS) in patients with primary Sjögren’s syndrome (SS) not responding to standard treatment with artificial tears

  P. Ostuni, M.E.C. Battista, A. Furlan

  119-124

  Published:

  922

  PDF: 1945
• 

  Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

  M. Rossini, O Viapiana, G. Orsolini, E. Fracassi, L. Idolazzi, D. Gatti, S. Adami, M. Govoni

  285-303

  31-03-2015

  Published: 31 March 2015

  2338

  PDF: 2190

• Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

  G. De Marco, V. Gerloni, I. Pontikaki, A. Lurati, B. Teruzzi, A. Salmaso, E. Valcamonica, M. Gattinara, F. Fantini

  50-56

  Published:

  1078

  PDF: 720
• 

  Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency

  M.B. Ates, S. Karup, S. Ugurlu

  19-12-2023

  Published: 19 December 2023

  1019

  PDF: 273
• 

  GISEA: an Italian biological agents registry in rheumatology

  G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta

  155-164

  09-11-2011

  Published: 9 November 2011

  1906

  PDF: 1466
• 

  Association between red cell distribution width and response to methotrexate in rheumatoid arthritis

  M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi

  16-20

  10-04-2020

  Published: 10 April 2020

  1244

  PDF: 662

• Methotrexate in the treatment of peripheral arthritis in ulcerative colitis

  R. Peluso, M. Atteno, S. Iervolino, V. Bruner, F. Caso, L. Costa, M. Raimodo, M. Lofrano, F. Manguso, R. Scarpa

  15-20

  Published:

  1161

  PDF: 894
• 

  Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study

  R. Talotta, A. Berzi, F. Atzeni, D. Dell'Acqua, P. Sarzi Puttini, D. Trabattoni

  83-89

  09-09-2016

  Published: 9 September 2016

  1698

  PDF: 868

  IL RUOLO DEI LINFOCITI TH9 NELL'ARTRITE REUMATOIDE E NELLA RISPOSTA AL TRATTAMENTO CON INFLIXIMAB.: 0
• 

  A short history of anti-rheumatic therapy - V. Analgesics

  G. Pasero, P. Marson

  55-60

  Published:

  1428

  PDF: 1485
• 

  Clinical profile of patients with lupus psychosis in a Colombian cohort

  M. Muñoz-Urbano, J. Sánchez-Bautista, A. Ramirez, D.C. Quintero-González, Y. Santamaria-Alza, A.L. Vanegas-García

  13-09-2022

  Published: 13 September 2022

  1190

  PDF: 597
• 

  Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management

  R. Torta, F. Pennazio, V. Ieraci

  92-97

  06-06-2014

  Published: 6 June 2014

  2468

  PDF: 1664
• 

  Gait analysis in hip viscosupplementation for osteoarthritis: a case report

  L. Di Lorenzo

  199-202

  31-10-2013

  Published: 31 October 2013

  2781

  PDF: 794
• 

  Rheumatologic rehabilitation: the great expectation for rheumatic patients

  S. Maddali Bongi, M. Matucci Cerinic

  1-6

  16-03-2012

  Published: 16 March 2012

  596

  PDF: 751
• 

  Driving musculoskeletal health for Europe: EUMUSC.NET

  A.D. Woolf

  1-4

  Published:

  4174

  PDF: 690
• 

  A short history of anti-rheumatic therapy - VI. Rheumatoid arthritis drugs

  G. Pasero, P. Marson

  111-123

  Published:

  2075

  PDF: 1659
• 

  Pain in fibromyalgia and related conditions

  G. Cassisi, P. Sarzi-Puttini, R. Casale, M. Cazzola, L. Boccassini, F. Atzeni, S. Stisi

  72-86

  06-06-2014

  Published: 6 June 2014

  3797

  PDF: 2393

• The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients

  Dilia Giuggioli, Rocco Magistro, Michele Colaci, Umberto Franciosi, Andrea Caruso, Clodoveo Ferri

  26-30

  Published:

  925

  PDF: 1077